RENEE DAVIS: Open Payments
NPI 1558084590 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 12 payments from 8 companies in 2025. Trend: 2023 $301 · 2024 $149 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 2 | $42 |
| Mallinckrodt Hospital Products Inc. | 1 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Calliditas Therapeutics US Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Amgen Inc. | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
| SCPHARMACEUTICALS INC. | 1 | $14 |
Products named: IBSRELA, TERLIVAZ, Kerendia, TARPEYO, JARDIANCE, KRYSTEXXA, PURIFIED CORTROPHIN GEL, FUROSCIX.
Industry payments across OK — which companies pay providers there.
